Innovating Works

filtrando por convocatoria: HORIZON-JU-IHI-2022-01-04

GUIDE.MRD: GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Advancing personalized approaches in cancer therapy, aiding identification and adaptation of multi-modal treatment strategies for improved o...
2023-05-17 - 2028-04-30 | Financiado
PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE KAROLINSKA INSTITUTET tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million...
2023-04-25 - 2028-04-30 | Financiado
IMAGIO: IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY PHILIPS MEDICAL SYSTEMS NEDERLAND BV tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Lung and liver c...
2023-05-01 - 2027-04-30 | Financiado
IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-04-01 - 2028-03-31 | Financiado
CLAIMS: CLinical impact through AI-assisted MS care CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system. Since there is no cure available yet for MS...
2023-06-01 - 2027-05-31 | Financiado
IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-05-10 - 2028-03-31 | Financiado